20
Participants
Start Date
January 31, 2013
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
Cabazitaxel
25 mg/m2, IV (in the vein) on day 1 of each 21 day cycle. Number of Cycles: maximum 6
Best Supportive Care
Best Supportive Care including single agent chemotherapy as determined by the patient's study physician
University Hospitals Birmingham, Birmingham
Collaborators (1)
Sanofi
INDUSTRY
Dr Anjali Zarkar
OTHER